Skip to content

Effects of High Intensity Interval Training and Combined Training in Type 2 Diabetic (T2D) Patients

Effects of High Intensity Interval Training and Combined Training Associated With Photobiomodulation in Type 2 Diabetic (T2D) Patients: a Randomized Controlled Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03593746
Enrollment
60
Registered
2018-07-20
Start date
2020-08-01
Completion date
2022-12-31
Last updated
2022-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2, Exercise Training, High-Intensity Interval Training, Hyperglycaemia Due to Type 2 Diabetes Mellitus

Keywords

Cardiopulmonary Exercise Test, Rehabilitation, Diabetes Mellitus, Type 2, Functional Capacity, Photobiomodulation Therapy

Brief summary

Diabetes has become a widespread epidemic, primarily because of the increasing prevalence and incidence of type 2 diabetes (T2D). T2D is a significant cause of premature mortality and morbidity related to cardiovascular disease, blindness, kidney and nerve disease, and amputation. Physical activity improves blood glucose control and can prevent or delay T2D, along with positively affecting lipids, blood pressure, cardiovascular events, mortality, and quality of life. At present, although physical activity is a key element in the prevention and management of T2D, the most effective exercise strategy (intensity, duration, and type of exercise) for improving glucose control and reducing cardiometabolic risk in type 2 diabetes has not been defined. Studies with Light-Emitting Diode (LED) therapy have demonstrated its ability to promote pain relief, improve muscle and cardiopulmonary performance, minimize muscle fatigue, and stimulate wound healing. In relation to patients with T2D, who have prolonged conditions of hyperglycemia, studies to investigate the impact of photobiomodulation associated with physical training have not been found so far. The objective of this study is to investigate the effects of different types of physical training associated with Light-Emitting Diode (LED) therapy on cardiometabolic status and quality of life in patients with T2D.

Detailed description

Type 2 diabetes (T2D) is a significant health problem worldwide due to its high prevalence and mortality. It is chronic metabolic disorder characterized by hyperglycemia resulting from a relative deficiency in insulin through either reduced insulin secretion or reduced insulin action or both. The subsequent chronic hyperglycaemia causes glycation of tissues, which almost inevitably leads to acute disturbances in metabolism and long term end organ damage, especially the blood vessels, heart, and nerves, and severe health complications. Individuals with T2D have reduced aerobic fitness characterized by lower peak pulmonary oxygen uptake. Many potential mechanisms could explain this impaired response, for example, reduced muscle blood flow and capillary density, defects in muscular oxygen diffusion, and lower mitochondrial oxygen utilization and function. T2D is also associated with lower baroreflex sensitivity and abnormal chronotropic response, altering heart rate regulation. In addition, prolonged hyperglycemia in T2D causes a number of pathological changes in vascular endothelial cells, increasing the production of reactive oxygen species and inflammatory cytokines that cause mitochondrial dysfunction and oxidative damage.

Interventions

OTHERPhysical training

Type 2 diabetic patients will be subjected to different types of physical training (high intensity interval training or combined training).

OTHERLight-Emitting Diode (LED) therapy

Type 2 diabetic patients will be subjected to Light-Emitting Diode (LED) therapy (active or sham).

Sponsors

University of Nove de Julho
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years; * Confirmed diagnosis of type 2 diabetes; * Sedentary lifestyle in the last six months, according to the criteria established by the American Heart Association (AHA).

Exclusion criteria

* Confirmed diagnosis of any (1) heart disease; (2) musculoskeletal disorder; (3) respiratory disease; (4) uncontrolled arterial hypertension; (5) peripheral neuropathy or (6) factors that limit the performance of any of the study evaluations and/or training. * During the study, individuals with a presence of less than 80% in the training sessions will be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Functional exercise capacityChange from Baseline to 12 weeksOxygen consumption measurement during cardiopulmonary test
Incremental shuttle walking testChange from Baseline to 12 weeksDistance in meters
Glycemic controlChange from Baseline to 12 weeksEvaluated by the percentage of glycated hemoglobin

Secondary

MeasureTime frameDescription
Endothelial FunctionChange from Baseline to 12 weeksEndothelial function will be assessed by arterial flow-mediated dilation (FMD)
Quality of Life QuestionaryChange from Baseline to 12 weeksAssesment by using the questionnaire Medical Outcomes Study 36 - Item Short - Form Health Survey (SF36). The SF-36 has eight sections (Vitality, Physical functioning, Bodily pain, General health perceptions, Physical role functioning, Emotional role functioning, Social role functioning and Mental health). The scores are weighted sums of the questions in each section. Scores range from 0 - 100. Lower scores = more disability and higher scores = less disability.
Autonomic Nervous SystemChange from Baseline to 12 weeksAssesment by Heat Rate Variability analysis
Other Biochemical AnalyzesChange from Baseline to 12 weeksTotal cholesterol (Total-C) (mg/dl), low-density lipoprotein cholesterol (LDL-C) (mg/dl), high-density lipoprotein cholesterol (HDL-C) (mg/dl) and triglycerides (mg/dl)
Body mass index (BMI)Change from Baseline to 12 weeksWeight and height will be combined to report BMI (kg/m2)
Musculoskeletal FunctionChange from Baseline to 12 weeksMuscular strength and endurance will be evaluated by Isokinetic Dynamometry
Physical Activity QuestionnaireChange from Baseline to 12 weeksThe level of physical activity will be assessed using the international questionnaire short version physical activity (IPAQ). The continuous score allows assessing energy expenditure expressed in MET minutes/week. The IPAQ categories include: Insufficiently active (does not perform any physical activity); Sufficiently active (conducts vigorous activity at least three days a week \>600 MET - 1400 MET); Very active (performs more than three days per week of vigorous activity 1500 MET - 3000 MET).

Countries

Brazil

Contacts

Primary ContactLuciana MM Sampaio, Professor
lucianamalosa@gmail.com+551133859241
Backup ContactCauê Padovani, Phd
cauepadovani@hotmail.com+55969288228

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026